Literature DB >> 19583970

Antenatal glucocorticoid therapy increase cardiac alpha-enolase levels in fetus and neonate rats.

Yoshimitsu Tsuzuki1, Yuko Takeba, Toshio Kumai, Naoki Matsumoto, Masanori Mizuno, Kotaro Murano, Kentaro Asoh, Masayuki Takagi, Hitoshi Yamamoto, Shinichi Kobayashi.   

Abstract

AIMS: Antenatal glucocorticoid therapy has been shown to prevent acute diseases including infant respiratory distress syndrome and reduce mortality, although little is known about the effects on cardiac function-related proteins in the fetus or neonate. We investigated whether cardiac function-related proteins were altered in cardiac tissues of fetuses and neonates born to pregnant rats treated by glucocorticoid. MAIN
METHODS: Dexamethasone (DEX) was administered to pregnant rats for 2 days on day 17 and 18 or day 19 and 20 of gestation to simulate antenatal DEX therapy, and cardiac tissues of 19- and 21-day fetuses and 1-, 3-, and 5-day neonates were analyzed using a proteomic technique with liquid chromatography-mass spectrometry/mass spectrometry. KEY
FINDINGS: The identified five proteins; alpha-enolase, creatine kinase-M type, beta-tubulin, troponin T, and ATP synthase beta-chain, were significantly increased in fetal cardiac tissues with DEX administration. We observed that significant increase of alpha-enolase in the 19-day fetuses by DEX using Western blotting and immunohistochemistry. ATP and cAMP levels were also increased in the fetal heart tissue. In addition, pyruvate levels were significantly increased in the fetus groups by DEX. SIGNIFICANCE: These results suggest that increased alpha-enolase may contribute to acceleration of glycolysis in the preterm heart.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19583970     DOI: 10.1016/j.lfs.2009.06.017

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Prenatal glucocorticoid administration accelerates the maturation of fetal rat hepatocytes.

Authors:  Tsukasa Kobayashi; Yuko Takeba; Yuki Ohta; Masanori Ootaki; Keisuke Kida; Minoru Watanabe; Taroh Iiri; Naoki Matsumoto
Journal:  Mol Biol Rep       Date:  2022-03-19       Impact factor: 2.742

Review 2.  Metabolic Consequences of Glucocorticoid Exposure before Birth.

Authors:  Abigail L Fowden; Owen R Vaughan; Andrew J Murray; Alison J Forhead
Journal:  Nutrients       Date:  2022-05-30       Impact factor: 6.706

Review 3.  Antenatal Glucocorticoid Administration Promotes Cardiac Structure and Energy Metabolism Maturation in Preterm Fetuses.

Authors:  Kenzo Sakurai; Yuko Takeba; Yosuke Osada; Masanori Mizuno; Yoshimitsu Tsuzuki; Kentaro Aso; Keisuke Kida; Yuki Ohta; Masanori Ootaki; Taroh Iiri; Isamu Hokuto; Naoki Shimizu; Naoki Matsumoto
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

Review 4.  Glucocorticoids, antenatal corticosteroid therapy and fetal heart maturation.

Authors:  Emma J Agnew; Jessica R Ivy; Sarah J Stock; Karen E Chapman
Journal:  J Mol Endocrinol       Date:  2018-05-02       Impact factor: 5.098

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.